GC203 TIL

BIOLOGICAL2 trials

Sponsors

Shanghai Juncell Therapeutics

Conditions

Pancratic Ductal AdenocarcinomaPancreatic CancerSolid Tumors, AdultTreatment Side EffectsTumor Infiltrating Lymphocytes

Early Phase 1

A Study of GC203 TIL in PDCA (RJ)

RecruitingNCT06828328

Shanghai Juncell TherapeuticsPancratic Ductal Adenocarcinoma, Pancreatic Cancer, Treatment Side Effects +1

Start: 2025-02-10End: 2028-01-31Target: 10Updated: 2026-08-05

Phase 1

A Study of GC203 TIL in Advanced Solid Tumors (NF)

RecruitingNCT07256756

Shanghai Juncell TherapeuticsSolid Tumors, Adult

Start: 2026-01-30End: 2028-11-30Target: 8Updated: 2026-08-05